Angiogenic stem cell delivery platform to augment post-infarction neovasculature and reverse ventricular remodeling

Many cell-based therapies are challenged by the poor localization of introduced cells and the use of biomaterial scaffolds with questionable biocompatibility or bio-functionality. Endothelial progenitor cells (EPCs), a popular cell type used in cell-based therapies due to their robust angiogenic pot...

Descripción completa

Detalles Bibliográficos
Autores principales: Shin, Hye Sook, Thakore, Akshara, Tada, Yuko, Pedroza, Albert J., Ikeda, Gentaro, Chen, Ian Y., Chan, Doreen, Jaatinen, Kevin J., Yajima, Shin, Pfrender, Eric M., Kawamura, Masashi, Yang, Phillip C., Wu, Joseph C., Appel, Eric A., Fischbein, Michael P., Woo, YJoseph, Shudo, Yasuhiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9584918/
https://www.ncbi.nlm.nih.gov/pubmed/36266453
http://dx.doi.org/10.1038/s41598-022-21510-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9584918/
https://www.ncbi.nlm.nih.gov/pubmed/36266453
http://dx.doi.org/10.1038/s41598-022-21510-y

Ejemplares similares